E-sea Bio-medical Engineering

E-Sea Biomedical Engineering Co. International, Ltd. was a medical device company based in Shenzhen, China, specializing in the development of breast cancer detection technology. The company's flagship product, the "Three-operator Mammary Gland Detecting System," was a non-invasive and low-cost diagnostic tool designed to provide an alternative to traditional mammography. In 2004, the company was acquired by Eternal Technologies Group, Inc., a firm involved in agricultural genetics and biotechnology. Although the company initially reported a significant backlog of orders and plans for international expansion, its parent company faced regulatory challenges, leading to the revocation of its SEC registration in 2011. Consequently, E-Sea Biomedical Engineering is no longer active as a standalone entity or a public subsidiary.